Barriers to the implementation of prehospital thrombolysis in the treatment of ST-segment elevation myocardial infarction in South Africa: An exploratory inquiry
- PMID: 33299757
- PMCID: PMC7700957
- DOI: 10.1016/j.afjem.2020.08.001
Barriers to the implementation of prehospital thrombolysis in the treatment of ST-segment elevation myocardial infarction in South Africa: An exploratory inquiry
Abstract
Introduction: Evidence-based guidelines advocate percutaneous coronary intervention (PCI) as the mainstay reperfusion strategy for ST-segment elevation myocardial infarction (STEMI). However, the South African health system is not well positioned to provide PCI as a 'mainstay strategy'. In response, the Health Professions Council of South Africa approved the use of prehospital thrombolysis (PHT) for emergency care practitioners in 2009. However, since its approval, prehospital thrombolysis has failed to reach a level of systematic uptake indicative of successful implementation. The current study aimed to explore, through a qualitative inquiry, barriers to PHT for the treatment of myocardial infarction within a South African context.
Methods: A qualitative single-case study design was used where a series of semi-structured interviews were conducted involving purposefully selected participants. The case comprised a nationalised private emergency medical service, and participants were selected in view of relevant experience and knowledge. Requisite data was conceptualised through the consolidated framework for implementation research, and thematic analysis outlined the data coding procedures of the study.
Results: The study identified potential barriers to the implementation of PHT. These comprised cost, logistics, inter-professional collaboration, leadership engagement, and beliefs or scepticism associated with PHT.
Conclusion: A lack of strategic implementation has resulted in a poor introduction of evidenced-based prehospital cardiac care, affecting vulnerable populations who may have otherwise benefited from receiving this level of care. Given the time-sensitive nature of STEMI management, and severely limited access to 'primary reperfusion', PHT resembles not only a logical but also appealing solution in the South African context.
Keywords: Acute myocardial infarction; Implementation; Prehospital coronary care; Prehospital thrombolysis; St-segment myocardial infarction.
© 2020 African Federation for Emergency Medicine. Publishing services provided by Elsevier.
Similar articles
-
Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction.JAMA. 2006 Oct 11;296(14):1749-56. doi: 10.1001/jama.296.14.1749. JAMA. 2006. PMID: 17032988
-
Pre-hospital thrombolysis for ST-segment elevation myocardial infarction in regional Australia: long-term follow up.Intern Med J. 2020 Jun;50(6):711-715. doi: 10.1111/imj.14412. Intern Med J. 2020. PMID: 31237408
-
Pros, cons, and organization of prehospital thrombolysis.Clin Ther. 2013 Aug;35(8):1058-63. doi: 10.1016/j.clinthera.2013.07.425. Clin Ther. 2013. PMID: 23973038 Review.
-
Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia.BMJ Open Qual. 2021 Dec;10(4):e001519. doi: 10.1136/bmjoq-2021-001519. BMJ Open Qual. 2021. PMID: 34872989 Free PMC article.
-
Informing Utstein-style reporting guidelines for prehospital thrombolysis: A scoping review.Australas Emerg Care. 2024 Jun;27(2):148-154. doi: 10.1016/j.auec.2023.12.001. Epub 2024 Jan 16. Australas Emerg Care. 2024. PMID: 38233295
Cited by
-
A resuscitation systems analysis for South Africa: A narrative review.Resusc Plus. 2024 May 9;18:100655. doi: 10.1016/j.resplu.2024.100655. eCollection 2024 Jun. Resusc Plus. 2024. PMID: 38770395 Free PMC article. Review.
-
Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review.PLoS Med. 2022 Jul 25;19(7):e1004055. doi: 10.1371/journal.pmed.1004055. eCollection 2022 Jul. PLoS Med. 2022. PMID: 35877677 Free PMC article.
-
Acute coronary syndromes.Lancet. 2022 Apr 2;399(10332):1347-1358. doi: 10.1016/S0140-6736(21)02391-6. Lancet. 2022. PMID: 35367005 Free PMC article. Review.
-
Adverse events of tissue plasminogen activators in acute myocardial infarction patients: a real-world and pharmacovigilance database analysis.BMC Cardiovasc Disord. 2024 Aug 23;24(1):441. doi: 10.1186/s12872-024-04121-5. BMC Cardiovasc Disord. 2024. PMID: 39179962 Free PMC article.
References
-
- O’Gara P., Kushner F., Ascheim D., Casey D., Jr., Chung M., de Lemos J. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013:82:E1–27. doi: 10.1002/ccd.24776. - DOI - PubMed
-
- Naidoo R. University of the Witwatersrand; 2014. Thrombolytic therapy for acute myocardial infarction by emergency care practitioners.
LinkOut - more resources
Full Text Sources
Miscellaneous